Discontinued — last reported Q3 '25
Allstate Equity Method Investments increased by 1.2% to $8.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.6%, from $9.38B to $8.95B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 14.2% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.07B | $7.58B | $8.02B | $7.98B | $7.94B | $7.91B | $8.11B | $7.97B | $8.15B | $8.36B | $8.38B | $8.56B | $8.73B | $8.93B | $9.26B | $9.38B | $9.19B | $9.21B | $8.84B | $8.95B |
| QoQ Change | — | +7.1% | +5.8% | -0.5% | -0.4% | -0.5% | +2.6% | -1.8% | +2.2% | +2.6% | +0.2% | +2.2% | +2.0% | +2.2% | +3.7% | +1.4% | -2.0% | +0.2% | -4.0% | +1.2% |
| YoY Change | — | — | — | — | +12.3% | +4.3% | +1.2% | -0.1% | +2.6% | +5.8% | +3.3% | +7.4% | +7.1% | +6.7% | +10.4% | +9.6% | +5.3% | +3.2% | -4.4% | -4.6% |